These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2954751)

  • 1. [Changes in blood potassium induced by the abuse of 3 beta 2-agonist drugs].
    Capretti A; Dantes M; De Gasperi R; D'Ambrosio V
    Clin Ter; 1987 Apr; 121(1):41-4. PubMed ID: 2954751
    [No Abstract]   [Full Text] [Related]  

  • 2. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
    Jaffé G; Grimshaw JJ
    Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Deterioration of ventilation parameters following inhalation of fenoterol and salbutamol].
    Szafrański W
    Pol Arch Med Wewn; 1981 Jan; 65(1):41-7. PubMed ID: 7291027
    [No Abstract]   [Full Text] [Related]  

  • 4. [Novel quantitative assessment of the tremorogenic effects of the beta 2-mimetics clenbuterol and salbutamol after oral administration].
    Schaffler K; Schuster D
    Arzneimittelforschung; 1985; 35(8):1299-302. PubMed ID: 3907640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
    Ulmer WT; Scholz HJ; Baines A
    Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fenoterol in the treatment of bronchial obstruction in chronic asthmatiform bronchitis].
    Montanari S; Pasqua F; Gramiccioni E
    Clin Ter; 1982 Jul; 102(2):131-8. PubMed ID: 6216039
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypoxemic effect of selective beta-2 adrenergic stimulants administered by the subcutaneous route].
    Díez Jarilla JL; del Pino Montes J; Cruz Hernández JJ; Sánchez Gascón F; de Castro del Pozo S
    Med Clin (Barc); 1982 Sep; 79(5):215-8. PubMed ID: 7144302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fenoterol in the diagnosis and treatment of reversible bronchospasm].
    Sevieri GP; Quartieri F; Del Bono N
    Clin Ter; 1981 Dec; 99(6):615-22. PubMed ID: 7333073
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
    Vollmer M; Schmidt EW; Ulmer WT
    Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the bronchodilating effect of TH 1165 A and of salbutamol in patients with spastic obstructive ventilatory syndrome].
    Iaia E; Cagnazzo R; Digilio VS; Scoditti A
    Clin Ter; 1981 Dec; 99(5):499-505. PubMed ID: 7333071
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tocolysis with clenbuterol tablets].
    Kovács L; Mészáros G; Pál A; Szász K
    Zentralbl Gynakol; 1987; 109(22):1368-73. PubMed ID: 3324563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenoterol and serum potassium.
    Martelli A; Otero C; Gil B; Gonzalez S
    Lancet; 1989 May; 1(8648):1197. PubMed ID: 2566751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of propellant on airway resistance in patients with respiratory diseases and in humans with healthy lungs].
    Islam MS; Zülchner de Andrade M
    Prax Klin Pneumol; 1982 Dec; 36(12):500-1. PubMed ID: 7163128
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combined treatment with ipratropin and fenoterol in chronic obstructive lung disease].
    Langaker O
    Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):558-9. PubMed ID: 6218649
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fenoterol (Berotec)].
    Pedersen JT
    Ugeskr Laeger; 1976 Nov; 138(45):2817-8. PubMed ID: 790715
    [No Abstract]   [Full Text] [Related]  

  • 18. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypokalaemia induced by inhalation of fenoterol.
    Haalboom JR; Deenstra M; Struyvenberg A
    Lancet; 1985 May; 1(8438):1125-7. PubMed ID: 2860336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenoterol inhalation: its associated risks and potential benefits when reducing serum potassium levels.
    de los Santos CA; Traesel MA; Marini L
    Clin Nephrol; 1998 Jun; 49(6):390. PubMed ID: 9696438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.